BIONOMICS LIMITED - Announcements

0.00%

1.0¢

Currently unlisted.

Bionomics Limited (Bionomics) is an Australia-bases clinical-stage biopharmaceutical... Bionomics Limited (Bionomics) is an Australia-bases clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of novel, ion channel targeting drug candidates designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders. The Company operates in drug development segment in Australia. The Company is advancing its lead drug candidate, BNC210, which is an oral, proprietary, selective negative allosteric modulator of the a7 nicotinic acetylcholine receptor, for the acute treatment of Social Anxiety Disorder (SAD) and chronic treatment of Post-Traumatic Stress Disorder (PTSD). The Company has two drugs in early-stage clinical trials for the treatment of cognitive deficits in Alzheimer’s disease and other central nervous system conditions.More

ASX:PAR

This stock could have something close to a cure for osteoarthritis. Paradigm Biopharmaceuticals (ASX:PAR) is a late-stage drug development company working first and foremost to create a superior treatment for osteoarthritis.

Announcements

Filter Results

All Price Sensitive Only

BNO	Appendix 3B		04/03/13	141.96KB	Share
BNO	Underwritten Rights Issue to Raise $16.4 Million	PRICE SENSITIVE	04/03/13	61.52KB	Share
BNO	Trading Halt	PRICE SENSITIVE	28/02/13	138.68KB	Share
BNO	Appendix 3B		15/02/13	191.94KB	Share
BNO	Half Yearly Report and Accounts	PRICE SENSITIVE	14/02/13	218.59KB	Share
BNO	BNO Provides BNC101 Update at US Cancer Stem Cell Conference	PRICE SENSITIVE	11/02/13	36.77KB	Share
BNO	BNC375 Alzheimer's Disease Data Presented at Conference	PRICE SENSITIVE	04/02/13	83.51KB	Share
BNO	Bionomics NOW February 2013 Newsletter		01/02/13	1.24MB	Share
BNO	Appendix 3B		31/01/13	192.05KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/13	72.19KB	Share
BNO	Bionomics R&D Tax Incentive for FY2012	PRICE SENSITIVE	15/01/13	45.99KB	Share
BNO	CEO Update and US Investor Presentation	PRICE SENSITIVE	09/01/13	54.69KB	Share
BNO	Final Director's Interest Notice		03/01/13	12.91KB	Share
BNO	BNC210 US TRIAL	PRICE SENSITIVE	21/12/12	46.7KB	Share
BNO	Appendix 3B		21/12/12	192.62KB	Share
BNO	Bionomics New Alzheimer's Drug Candidate	PRICE SENSITIVE	14/12/12	94.42KB	Share
BNO	Appendix 3B		12/12/12	192.39KB	Share
BNO	Change of Director's Interest Notice		12/12/12	112.56KB	Share
BNO	Change of Director's Interest Notice		12/12/12	111.66KB	Share
BNO	Change of Director's Interest Notice		12/12/12	111.8KB	Share
BNO	Annual General Meeting 2012 Results		14/11/12	28.55KB	Share
BNO	Outgoing Chairman's Address		14/11/12	38.9KB	Share
BNO	CEO & Managing Director AGM Presentation 2012	PRICE SENSITIVE	14/11/12	388.61KB	Share
BNO	CEO Broadcast - IND Application for Anti-Anxiety Drug		09/11/12	25.63KB	Share
BNO	IND Submission to FDA for BNC210 Anti-Anxiety Drug Candidate	PRICE SENSITIVE	08/11/12	47.58KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/12	38.38KB	Share
BNO	Change in substantial holding		29/10/12	73KB	Share
BNO	Bionomics ASX Small to Mid Caps Investor Presentation		17/10/12	2.11MB	Share
BNO	ALPHA 7 PROGRAM TO BE SHOWCASED AT NEUROSCIENCE 2012	PRICE SENSITIVE	16/10/12	90.99KB	Share
BNO	Notice of Annual General Meeting/Proxy Form		12/10/12	402.26KB	Share
BNO	Bionomics Annual Report 2012		12/10/12	4.07MB	Share
BNO	Retirement of Chairman		11/10/12	29.61KB	Share
BNO	Change of Director's Interest Notice		05/10/12	111.99KB	Share
BNO	Appendix 3B		03/10/12	192.48KB	Share
BNO	Change of Director's Interest Notice		02/10/12	112.51KB	Share
BNO	Change of Director's Interest Notice		26/09/12	76.37KB	Share
BNO	Appendix 3B		26/09/12	136.67KB	Share
BNO	Cleansing Notice Under Section 708A of the Corporations Act		26/09/12	53.02KB	Share
BNO	Initial Director's Interest Notice		20/09/12	103.99KB	Share
BNO	Initial Director's Interest Notice		20/09/12	103.74KB	Share
BNO	Change in substantial holding		18/09/12	73.38KB	Share
BNO	Bionomics Appoints Graeme Kaufman Non-Executive Director		18/09/12	26.36KB	Share
BNO	BNO Acquires US-Based Cancer Stem Cell Company Presentation		17/09/12	351.28KB	Share
BNO	Bionomics Acquires US-Based Cancer Stem Cell Company	PRICE SENSITIVE	17/09/12	43.28KB	Share
BNO	Bionomics Key Additions to Executive Team		12/09/12	38.11KB	Share
BNO	FDA Approval for Ironwood	PRICE SENSITIVE	31/08/12	28.64KB	Share
BNO	Appendix 3B		21/08/12	192.05KB	Share
BNO	Bionomics August 2012 Investor Presentation		17/08/12	2.14MB	Share
BNO	Change of Director's Interest Notice		15/08/12	111.81KB	Share
BNO	Full Year Statutory Accounts		15/08/12	789.74KB	Share
BNO	Bionomics' 2011/2012 Preliminary Final Results	PRICE SENSITIVE	15/08/12	57.53KB	Share
BNO	Bionomics Secures Key US Patent for VDA BNC105	PRICE SENSITIVE	15/08/12	36.09KB	Share
BNO	Appendix 3B		02/08/12	102.03KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/12	38.07KB	Share
BNO	Bionomics NOW July 2012 Newsletter		06/07/12	2.77MB	Share
BNO	Open Briefing - CEO on Kv1.3 Program and Outlook	PRICE SENSITIVE	27/06/12	196.67KB	Share
BNO	US Patent Granted for Kv1.3 Program	PRICE SENSITIVE	26/06/12	34.98KB	Share
BNO	Change of Director's Interest Notice		19/06/12	112.4KB	Share
BNO	Appendix 3B		15/06/12	172.16KB	Share
BNO	Bionomics to Expand KV1.3 Program	PRICE SENSITIVE	15/06/12	37.91KB	Share
BNO	CEO Broadcast - BNC105 Trial Data		13/06/12	25.66KB	Share
BNO	BNC105 Trial Data Presented at ASCO	PRICE SENSITIVE	01/06/12	43.57KB	Share
BNO	Bionomics Launches BNC105 Ovarian Cancer Trial	PRICE SENSITIVE	24/05/12	47.41KB	Share
BNO	Life Sciences Conference Investor Presentation		23/05/12	1.43MB	Share
BNO	Change of Director's Interest Notice		07/05/12	76.03KB	Share
BNO	Appendix 3B		03/05/12	106.41KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/12	38.12KB	Share
BNO	Joint Bionomics and Ironwood Roadshow		18/04/12	856.46KB	Share
BNO	Change of Director's Interest Notice		17/04/12	77.04KB	Share
BNO	Appendix 3B		17/04/12	106.13KB	Share
BNO	Open Briefing - CEO on BNC105 Ovarian Cancer Trial	PRICE SENSITIVE	03/04/12	208.24KB	Share
BNO	BNC105 Ovarian Cancer Progress	PRICE SENSITIVE	02/04/12	41.94KB	Share
BNO	Appendix 3B		27/03/12	120.45KB	Share
BNO	BNC105 Ovarian Cancer Trial Approved	PRICE SENSITIVE	23/03/12	42.41KB	Share
BNO	Appendix 3B		06/03/12	170.6KB	Share
ABC +PRX CQE AGI AGS ALK ASB BCI BKY BMN BNO BPT BRM BRV CCU CHN CIF CLO CVC CVN CXM DLS DMG EGO WJA EXS FND GCS JNS GFF GWR GZL HGO HSN HST IPD IPP IXR KZL LNG MCO MEL MEO NDO	SandP Indices Announces March Quarterly Rebalance		02/03/12	144.47KB	Share
BNO	US and UK Investor Presentation		01/03/12	2.21MB	Share
BNO	Change of Director's Interest Notice		21/02/12	111.95KB	Share
BNO	Bionomics NOW February 2012 Newsletter		21/02/12	749.13KB	Share
BNO	CEO Broadcast - BNO Targets Alzheimer's Disease		20/02/12	25.7KB	Share
BNO	Appendix 3B		16/02/12	171.73KB	Share
BNO	Bionomics Targets Alzheimer's Disease	PRICE SENSITIVE	16/02/12	101.46KB	Share
BNO	Half Yearly Report and Accounts	PRICE SENSITIVE	14/02/12	397.42KB	Share
BNO	BNC105 Renal Cancer Trial Data Presented at ASCO-GU	PRICE SENSITIVE	03/02/12	41.05KB	Share
BNO	Appendix 3B		31/01/12	171.13KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/12	70.91KB	Share
BNO	Appendix 3B		23/01/12	171.05KB	Share
BNO	Appendix 3B		16/01/12	172.59KB	Share
BNO	CEO Biotech Showcase Presentation 2012		09/01/12	1MB	Share
BNO	CEO Update and US Investor Presentation		09/01/12	24.99KB	Share
BNO	Audio Broadcast - CEO Discusses Ironwood Agreement		05/01/12	25.72KB	Share
BNO	Ironwood and Bionomics Announce Agreement	PRICE SENSITIVE	05/01/12	211.42KB	Share
BNO	Trading Halt	PRICE SENSITIVE	04/01/12	292.83KB	Share
BNO	Ceasing to be a substantial holder		21/12/11	27.79KB	Share
BNO	Change in substantial holding		20/12/11	56.62KB	Share
BNO	Becoming a substantial holder		19/12/11	71.28KB	Share
BNO	Appendix 3B		16/12/11	172.12KB	Share
BNO	Investor Presentation - December 2011		14/12/11	1017.59KB	Share
BNO	Amended Change of Director's Interest Notice		29/11/11	77.08KB	Share
BNO	Appendix 3B		29/11/11	107.86KB	Share

BNOAppendix 3B
04/03/13		141.96KB	Share
BNOUnderwritten Rights Issue to Raise $16.4 Million
04/03/13	PRICE SENSITIVE	61.52KB	Share
BNOTrading Halt
28/02/13	PRICE SENSITIVE	138.68KB	Share
BNOAppendix 3B
15/02/13		191.94KB	Share
BNOHalf Yearly Report and Accounts
14/02/13	PRICE SENSITIVE	218.59KB	Share
BNOBNO Provides BNC101 Update at US Cancer Stem Cell Conference
11/02/13	PRICE SENSITIVE	36.77KB	Share
BNOBNC375 Alzheimer's Disease Data Presented at Conference
04/02/13	PRICE SENSITIVE	83.51KB	Share
BNOBionomics NOW February 2013 Newsletter
01/02/13		1.24MB	Share
BNOAppendix 3B
31/01/13		192.05KB	Share
BNOAppendix 4C - quarterly
31/01/13	PRICE SENSITIVE	72.19KB	Share
BNOBionomics R&D Tax Incentive for FY2012
15/01/13	PRICE SENSITIVE	45.99KB	Share
BNOCEO Update and US Investor Presentation
09/01/13	PRICE SENSITIVE	54.69KB	Share
BNOFinal Director's Interest Notice
03/01/13		12.91KB	Share
BNOBNC210 US TRIAL
21/12/12	PRICE SENSITIVE	46.7KB	Share
BNOAppendix 3B
21/12/12		192.62KB	Share
BNOBionomics New Alzheimer's Drug Candidate
14/12/12	PRICE SENSITIVE	94.42KB	Share
BNOAppendix 3B
12/12/12		192.39KB	Share
BNOChange of Director's Interest Notice
12/12/12		112.56KB	Share
BNOChange of Director's Interest Notice
12/12/12		111.66KB	Share
BNOChange of Director's Interest Notice
12/12/12		111.8KB	Share
BNOAnnual General Meeting 2012 Results
14/11/12		28.55KB	Share
BNOOutgoing Chairman's Address
14/11/12		38.9KB	Share
BNOCEO & Managing Director AGM Presentation 2012
14/11/12	PRICE SENSITIVE	388.61KB	Share
BNOCEO Broadcast - IND Application for Anti-Anxiety Drug
09/11/12		25.63KB	Share
BNOIND Submission to FDA for BNC210 Anti-Anxiety Drug Candidate
08/11/12	PRICE SENSITIVE	47.58KB	Share
BNOAppendix 4C - quarterly
31/10/12	PRICE SENSITIVE	38.38KB	Share
BNOChange in substantial holding
29/10/12		73KB	Share
BNOBionomics ASX Small to Mid Caps Investor Presentation
17/10/12		2.11MB	Share
BNOALPHA 7 PROGRAM TO BE SHOWCASED AT NEUROSCIENCE 2012
16/10/12	PRICE SENSITIVE	90.99KB	Share
BNONotice of Annual General Meeting/Proxy Form
12/10/12		402.26KB	Share
BNOBionomics Annual Report 2012
12/10/12		4.07MB	Share
BNORetirement of Chairman
11/10/12		29.61KB	Share
BNOChange of Director's Interest Notice
05/10/12		111.99KB	Share
BNOAppendix 3B
03/10/12		192.48KB	Share
BNOChange of Director's Interest Notice
02/10/12		112.51KB	Share
BNOChange of Director's Interest Notice
26/09/12		76.37KB	Share
BNOAppendix 3B
26/09/12		136.67KB	Share
BNOCleansing Notice Under Section 708A of the Corporations Act
26/09/12		53.02KB	Share
BNOInitial Director's Interest Notice
20/09/12		103.99KB	Share
BNOInitial Director's Interest Notice
20/09/12		103.74KB	Share
BNOChange in substantial holding
18/09/12		73.38KB	Share
BNOBionomics Appoints Graeme Kaufman Non-Executive Director
18/09/12		26.36KB	Share
BNOBNO Acquires US-Based Cancer Stem Cell Company Presentation
17/09/12		351.28KB	Share
BNOBionomics Acquires US-Based Cancer Stem Cell Company
17/09/12	PRICE SENSITIVE	43.28KB	Share
BNOBionomics Key Additions to Executive Team
12/09/12		38.11KB	Share
BNOFDA Approval for Ironwood
31/08/12	PRICE SENSITIVE	28.64KB	Share
BNOAppendix 3B
21/08/12		192.05KB	Share
BNOBionomics August 2012 Investor Presentation
17/08/12		2.14MB	Share
BNOChange of Director's Interest Notice
15/08/12		111.81KB	Share
BNOFull Year Statutory Accounts
15/08/12		789.74KB	Share
BNOBionomics' 2011/2012 Preliminary Final Results
15/08/12	PRICE SENSITIVE	57.53KB	Share
BNOBionomics Secures Key US Patent for VDA BNC105
15/08/12	PRICE SENSITIVE	36.09KB	Share
BNOAppendix 3B
02/08/12		102.03KB	Share
BNOAppendix 4C - quarterly
30/07/12	PRICE SENSITIVE	38.07KB	Share
BNOBionomics NOW July 2012 Newsletter
06/07/12		2.77MB	Share
BNOOpen Briefing - CEO on Kv1.3 Program and Outlook
27/06/12	PRICE SENSITIVE	196.67KB	Share
BNOUS Patent Granted for Kv1.3 Program
26/06/12	PRICE SENSITIVE	34.98KB	Share
BNOChange of Director's Interest Notice
19/06/12		112.4KB	Share
BNOAppendix 3B
15/06/12		172.16KB	Share
BNOBionomics to Expand KV1.3 Program
15/06/12	PRICE SENSITIVE	37.91KB	Share
BNOCEO Broadcast - BNC105 Trial Data
13/06/12		25.66KB	Share
BNOBNC105 Trial Data Presented at ASCO
01/06/12	PRICE SENSITIVE	43.57KB	Share
BNOBionomics Launches BNC105 Ovarian Cancer Trial
24/05/12	PRICE SENSITIVE	47.41KB	Share
BNOLife Sciences Conference Investor Presentation
23/05/12		1.43MB	Share
BNOChange of Director's Interest Notice
07/05/12		76.03KB	Share
BNOAppendix 3B
03/05/12		106.41KB	Share
BNOAppendix 4C - quarterly
30/04/12	PRICE SENSITIVE	38.12KB	Share
BNOJoint Bionomics and Ironwood Roadshow
18/04/12		856.46KB	Share
BNOChange of Director's Interest Notice
17/04/12		77.04KB	Share
BNOAppendix 3B
17/04/12		106.13KB	Share
BNOOpen Briefing - CEO on BNC105 Ovarian Cancer Trial
03/04/12	PRICE SENSITIVE	208.24KB	Share
BNOBNC105 Ovarian Cancer Progress
02/04/12	PRICE SENSITIVE	41.94KB	Share
BNOAppendix 3B
27/03/12		120.45KB	Share
BNOBNC105 Ovarian Cancer Trial Approved
23/03/12	PRICE SENSITIVE	42.41KB	Share
BNOAppendix 3B
06/03/12		170.6KB	Share
ABC +PRX CQE AGI AGS ALK ASB BCI BKY BMN BNO BPT BRM BRV CCU CHN CIF CLO CVC CVN CXM DLS DMG EGO WJA EXS FND GCS JNS GFF GWR GZL HGO HSN HST IPD IPP IXR KZL LNG MCO MEL MEO NDOSandP Indices Announces March Quarterly Rebalance
02/03/12		144.47KB	Share
BNOUS and UK Investor Presentation
01/03/12		2.21MB	Share
BNOChange of Director's Interest Notice
21/02/12		111.95KB	Share
BNOBionomics NOW February 2012 Newsletter
21/02/12		749.13KB	Share
BNOCEO Broadcast - BNO Targets Alzheimer's Disease
20/02/12		25.7KB	Share
BNOAppendix 3B
16/02/12		171.73KB	Share
BNOBionomics Targets Alzheimer's Disease
16/02/12	PRICE SENSITIVE	101.46KB	Share
BNOHalf Yearly Report and Accounts
14/02/12	PRICE SENSITIVE	397.42KB	Share
BNOBNC105 Renal Cancer Trial Data Presented at ASCO-GU
03/02/12	PRICE SENSITIVE	41.05KB	Share
BNOAppendix 3B
31/01/12		171.13KB	Share
BNOAppendix 4C - quarterly
31/01/12	PRICE SENSITIVE	70.91KB	Share
BNOAppendix 3B
23/01/12		171.05KB	Share
BNOAppendix 3B
16/01/12		172.59KB	Share
BNOCEO Biotech Showcase Presentation 2012
09/01/12		1MB	Share
BNOCEO Update and US Investor Presentation
09/01/12		24.99KB	Share
BNOAudio Broadcast - CEO Discusses Ironwood Agreement
05/01/12		25.72KB	Share
BNOIronwood and Bionomics Announce Agreement
05/01/12	PRICE SENSITIVE	211.42KB	Share
BNOTrading Halt
04/01/12	PRICE SENSITIVE	292.83KB	Share
BNOCeasing to be a substantial holder
21/12/11		27.79KB	Share
BNOChange in substantial holding
20/12/11		56.62KB	Share
BNOBecoming a substantial holder
19/12/11		71.28KB	Share
BNOAppendix 3B
16/12/11		172.12KB	Share
BNOInvestor Presentation - December 2011
14/12/11		1017.59KB	Share
BNOAmended Change of Director's Interest Notice
29/11/11		77.08KB	Share
BNOAppendix 3B
29/11/11		107.86KB	Share

REFRESH

First 5 6 7 8 9

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

BIONOMICS LIMITED - Announcements

Announcements

Clean energy vehicles with hydrogen production and distribution all under one roof

Prospect Resources continues to advance Mumbezhi project

Leeuwin Metals set to unlock significant gold potential at Marda

Haranga Resources: From uranium in Senegal to gold in the US

Top Stories